2020 | 2021 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Revenue | $19B | $19B | $17B | $16B | $15B |
Cost of Revenue | $17B | $17B | $14B | $13B | $0 |
Gross Profit | $2.2B | $2.1B | $2.5B | $2.9B | $0 |
Gross Profit % | 11% | 11% | 15% | 18% | 0% |
R&D Expenses | $76M | $0 | $0 | $0 | $0 |
2020 | 2021 | 2023 | 2024 | 2025 | |
---|---|---|---|---|---|
Net Income | -$2B | -$2.3B | -$1.4B | -$340M | $0 |
Dep. & Amort. | $1.9B | $1.7B | $1.4B | $1.2B | $0 |
Def. Tax | -$52M | -$401M | $285M | -$13M | $0 |
Stock Comp. | $64M | $71M | $113M | $95M | $0 |
Chg. in WC | -$1.3B | -$1.5B | -$1.3B | -$2.3B | $0 |
2019 | 2020 | 2021 | 2023 | 2024 | |
---|---|---|---|---|---|
Cash | $36M | $24M | $2.2B | $1.8B | $1.6B |
ST Investments | $0 | $0 | $0 | $0 | $0 |
Cash & ST Inv. | $36M | $24M | $2.2B | $1.8B | $1.6B |
Receivables | $1.8B | $1.4B | $2.3B | $1.5B | $1.6B |
Inventory | $1.1B | $1.4B | $1.3B | $1.1B | $0 |
Kyndryl delivered strong fiscal 2025 results, with signings up 48% to over $18B, adjusted pretax income up $317M to $482M, and adjusted free cash flow up 53% to $446M; Q4 marked a return to positive constant currency revenue growth.
Kyndryl Consult revenue grew over 25% for the year and 45% in Q4, with consult signings up 50% and now representing about 25% of total revenue; hyperscaler-related revenue more than doubled to $1.2B for the year.
The company’s “3A” initiatives (advanced delivery, accounts, alliances) surpassed targets, delivering $775M in annual savings from advanced delivery and $900M from accounts; focus account remediation is about 75% complete by revenue, with 90% of targeted savings already achieved.
Fiscal 2026 guidance includes: ~1% constant currency revenue growth, hyperscaler-related revenue of at least $1.8B (+50% YoY), double-digit Kyndryl Consult revenue growth, adjusted EBITDA margin of ~18%, adjusted pretax income of at least $725M (+$243M YoY), and adjusted free cash flow of ~$550M.
Management reiterated mid-term targets for fiscal 2028: over $1B in adjusted free cash flow and over $1.2B in adjusted pretax income, requiring only mid-single-digit revenue growth; capital allocation priorities include organic investment, tuck-in acquisitions, and continued share repurchases.